<DOC>
	<DOCNO>NCT00898313</DOCNO>
	<brief_summary>RATIONALE : Using sample blood , urine , sputum , lung tissue patient high risk cancer laboratory study may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This research study look molecular predictor cancer patient high risk lung cancer .</brief_summary>
	<brief_title>Molecular Predictors Cancer Patients High Risk Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To use fixed lung tissue histological evaluation fresh tissue sample molecular study study DNA , RNA , protein abnormality lung preneoplastic neoplastic lesion . - To use proteomic technique , include matrix-assisted laser desorption ionization-mass spectrometry ( MALDI-MS ) , develop method diagnose stag pre-invasive invasive lesion , use less invasive method . OUTLINE : Blood , urine , nasal cell , sputum sample collect . Lung tissue sample also collect use fluorescence bronchoscopy epithelial cell collection . Samples study genetic proteomic analysis , include comparative genomic hybridization , expression microarray , protein profiling .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>All adult refer Vanderbilt Medical Center , Veterans Administration Medical Center , St. Thomas Hospital Meharry Medical Center evaluation sign symptom lung cancer . Inability provide inform consent Minors Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>lung cancer</keyword>
</DOC>